Kenvue (KVUE) Insider Reports RSU Grant in Corrective Filing
Kenvue Inc.
Subscribe to track KVUE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Kenvue (KVUE) Insider Reports RSU Grant in Corrective Filing
Company: Kenvue Inc. (KVUE) Form: 4/A | Filed: 2025-12-17 Significance: Low
Insider: Dasgupta Anindya Title: Group President APAC | Relationship: Officer
Transaction: • Type: Grant • Shares: 32,649 Restricted Stock Units • Price: $0.00 • Value: $0 • Owned After: 48,147.25
Key Insight: This is a corrective filing (Form 4/A) to report an RSU grant to a group president that was previously omitted. The grant is part of routine executive compensation and has no immediate market value.
Market Context: As a non-cash compensation event for a $31.92B company, this grant is considered immaterial to the market. The shares vest over a three-year period starting in 2026.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Kenvue Inc. (KVUE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: This Form 4/A is a corrective filing to report a routine Restricted Stock Unit (RSU) grant to an officer, which was omitted from a previous report. The transaction has no immediate cash value and is part of a standard executive compensation plan.
- Market Impact: Neutral. This is a non-market transaction with negligible financial impact on the company.
Company Information
| Field | Value |
|---|---|
| Company | Kenvue Inc. |
| Ticker Symbol | KVUE |
| CIK | 0001944048 |
| Industry | Perfumes, Cosmetics & Other Toilet Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Dasgupta Anindya |
| CIK | 0002083814 |
| Title/Position | Group President APAC |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4/A |
| Transaction Date | 2025-07-31 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 32,649 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 48,147.25 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 32,649 |
| % of Shares Outstanding | Not Available |
| Post-Transaction Ownership | 48,147.25 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has a reported value of $0. As an equity grant, its notional value is insignificant compared to Kenvue's market capitalization of $31.92 billion.
- Ownership Concentration: The insider's total holdings remain a very small fraction of the company's total equity.
- Dilution Impact: While the exact percentage cannot be calculated without shares outstanding data, a grant of 32,649 shares is negligible for a large-cap company and will not result in any meaningful dilution for existing shareholders.
- Transaction Significance: The transaction is a routine part of executive compensation and holds low significance. Its main purpose is to align the executive's interests with shareholders over the long term, as the shares vest over three years.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market, non-cash transaction that was previously unreported. Corrective filings for routine compensation grants do not typically influence stock price.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is a grant, not an open-market trade.
- Sentiment Indicator: Neutral. The filing provides no new information that would shift market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: This is a Form 4/A, filed to amend a previous Form 4 from July 31, 2025, which inadvertently omitted this RSU grant. The award vests in three equal annual installments beginning July 31, 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
